Isarna Therapeutics

OverviewSuggest Edit

Isarna Therapeutics is a company that develops TGF-β inhibitors to treat ophthalmic and fibrotic diseases. Its solution offers oligonucleotides and combination modalities to transcend clinical response and manage patient outcomes.
TypePrivate
Founded2002
HQMünchen, DE
Websiteisarna-therapeutics.com

Locations

Isarna Therapeutics is headquartered in
München, Germany

Location Map

Latest Updates

Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Isarna Therapeutics Office Locations

Isarna Therapeutics has an office in München
München, DE (HQ)
Uhlandstraße 2
Show all (1)

Isarna Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2002

Isarna Therapeutics total Funding

$122.8 m

Isarna Therapeutics latest funding size

$7.6 m

Time since last funding

8 years ago

Isarna Therapeutics investors

Isarna Therapeutics's latest funding round in April 2014 was reported to be $7.6 m. In total, Isarna Therapeutics has raised $122.8 m
Show all financial metrics

Isarna Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Isarna Therapeutics Online and Social Media Presence

Embed Graph

Isarna Therapeutics Frequently Asked Questions

  • When was Isarna Therapeutics founded?

    Isarna Therapeutics was founded in 2002.

  • Who are Isarna Therapeutics competitors?

    Competitors of Isarna Therapeutics include Sigilon, Rubius Therapeutics and Confo Therapeutics.

  • Where is Isarna Therapeutics headquarters?

    Isarna Therapeutics headquarters is located at Uhlandstraße 2, München.

  • Where are Isarna Therapeutics offices?

    Isarna Therapeutics has an office in München.

  • How many offices does Isarna Therapeutics have?

    Isarna Therapeutics has 1 office.